Harms MH, Lammers WJ, Thorburn D, et al. Time Trends in Major Hepatic Complications in Primary Biliary Cholangitis: incidence and transplant-free survival. AASLD 2017, abstract 8.
Camrelizumab plus rivoceranib versus sorafenib als eerstelijnsbehandeling bij inoperabel HCC
nov 2023 | Hepatologie, Immuuntherapie, Maag-darm-leveroncologie